Sales growth of top pharmaceutical products in Canada 2022
In 2022, AbbVie's Humira saw a 37 percent decline in Canadian sales, caused by the loss of patent exclusivity during that year. Novo Nordisk's Ozempic was by far the fastest growing pharmaceutical product in that year. This statistic displays the growth of the 10 leading pharmaceutical products based on sales in Canada in 2022.